Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,949.00    -78.00 (-2.58%)
Bid:
2,942.00
Ask:
2,946.00
Spread: 4.00 (0.136%)
Market Cap: £4.11b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Interim Management Statement

25 Apr 2013 07:00

RNS Number : 1773D
Croda International PLC
25 April 2013
 



25 April 2013

 

Croda International Plc

 

AGM and Interim Management Statement

 

SOLID START TO 2013; OUTLOOK MAINTAINED

 

Croda International Plc today announces its Interim Management Statement for the period since 31 December 2012.

 

Pre-tax profits for the first quarter of 2013 were up 6.5% to £65.1m (2012: £61.1m). This was achieved against a particularly strong performance in the same period in 2012 and despite the adverse impact of an earlier Easter this year.

 

Group turnover grew marginally by 0.4% to £283.1m (2012: £281.9m). Consumer Care sales were broadly stable at £158.4m (2012: £159.1m), with Crop Care weaker due to the poor weather experienced in a number of regions throughout the period. Personal Care and Health Care sales were flat. Performance Technologies sales were also stable, down only 0.3% to £102.4m (2012: £102.7m) with continuing weakness in Lubricants being the major factor. Industrial Chemicals sales were up 10.4% at £22.3m (2012: £20.2m).

 

Group operating profits were up 4.0% to £68.0m (2012: £65.4m) increasing return on sales by a further 0.8 percentage points to 24.0% for the quarter. Profits and margins improved in all three of our reporting segments. Consumer Care profits increased 2.3% to £49.2m (2012: £48.1m) with return on sales up at 31.1% (2012: 30.2%). Performance Technologies profits increased 1.9% to £16.1m (2012: £15.8m) with return on sales up at 15.7% (2012: 15.4%). In Industrial Chemicals, profit increased to £2.7m (2012: £1.5m) as a result of the strong sales uplift and favourable commodity prices.

 

Interest costs decreased due to the reduced pension fund deficit, helping achieve the 6.5% increase in pre-tax profits referred to earlier.

 

There has been no significant change in Croda's financial position during the period. Underlying cash generation in the quarter continued to be good and at the end of March 2013 net debt was £211.1m, an increase of only £3.4m versus the year end despite a payment of £38m into the UK pension fund in January.

 

The Board believes that the Q1 result represents a solid start to the year. The outlook provided in February is unchanged and we expect to report further progress in 2013.

 

 

For further information, please contact:

 

Steve Foots, Group Chief Executive

Tel: 01405 860551

Sean Christie, Group Finance Director

Charlie Armitstead/ Rosie Oddy

Pendomer Communications

Tel: 020 3603 5220

 

The company will host a conference call for analysts at 8.00am (BST) today:

Dial-In: +44 203 426 2845

Please quote "Croda International"to gain access to the call

 

Croda International Plc

Unaudited income statement before tax and exceptional items

31 March 2013

 

3 months to

3 months to

31 March

31 March

2013

2012

Change

Consumer Care

158.4

159.1

-0.4%

Performance Technologies

102.4

102.7

-0.3%

Industrial Chemicals

22.3

20.1

+10.9%

Revenues from continuing operations

283.1

281.9

+0.4%

Consumer Care

49.2

48.1

+2.3%

Performance Technologies

16.1

15.8

+1.9%

Industrial Chemicals

2.7

1.5

+80.0%

Operating profit from continuing operations

68.0

65.4

+4.0%

Net bank and loan interest payable

(1.7)

(2.0)

Net retirement benefit scheme financing

(1.2)

(2.3)

Profit before tax from continuing operations

65.1

61.1

+6.5%

Operating margin

24.0%

23.2%

 

Analysis of turnover uplift for continuing operations

Volume

+0.1%

Mix and price

-0.9%

Underlying

-0.8%

Acquisitions

+0.1%

Currency translation

+1.1%

+0.4%

This statement has been prepared in accordance with the revised IAS19 rules regarding the accounting for post-retirement benefits. 2012 results have been restated so the figures are comparable.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGZDGDLGFZZ
Date   Source Headline
10th Oct 20243:39 pmRNSDirector/PDMR Shareholding
13th Sep 202410:07 amRNSDirector/PDMR Shareholding
11th Sep 20242:52 pmRNSDirector/PDMR Shareholding
13th Aug 20241:51 pmRNSDirector/PDMR Shareholding
30th Jul 20241:49 pmRNSDirector/PDMR Shareholding - Replacement
30th Jul 20241:40 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSResults for the six months ended 30 June 2024
12th Jul 202411:10 amRNSDirector Declaration
11th Jul 20242:21 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSCroda appoints Chief Financial Officer
25th Jun 202410:00 amRNSDirector/PDMR Shareholding
25th Jun 20247:00 amRNSDirectorate Change
13th Jun 20249:46 amRNSHolding(s) in Company
12th Jun 20249:01 amRNSDirector/PDMR Shareholding
11th Jun 20242:12 pmRNSDirector/PDMR Shareholding
30th May 20243:27 pmRNSDirector/PDMR Shareholding
30th May 20242:33 pmRNSDirector/PDMR Shareholding
13th May 20242:16 pmRNSDirector/PDMR Shareholding
2nd May 20249:27 amRNSDirector/PDMR Shareholding
1st May 202412:18 pmRNSDirector/PDMR Shareholding
25th Apr 202410:01 amRNSResult of AGM
24th Apr 20247:00 amRNSFirst quarter 2024 sales update
11th Apr 20242:11 pmRNSDirector/PDMR Shareholding
8th Apr 202410:54 amRNSDirector/PDMR Shareholding
8th Apr 202410:23 amRNSDirector/PDMR Shareholding
28th Mar 20249:17 amRNSDirector/PDMR Shareholding
26th Mar 20244:19 pmRNSDirector/PDMR Shareholding
26th Mar 20244:10 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSDirector/PDMR Shareholding
26th Mar 20244:06 pmRNSDirector/PDMR Shareholding
26th Mar 20244:04 pmRNSDirector/PDMR Shareholding
15th Mar 20249:32 amRNSAnnual Financial Report
12th Mar 20242:49 pmRNSDirector/PDMR Shareholding
7th Mar 20243:03 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSResults for the year ended 31 December 2023
13th Feb 20243:35 pmRNSDirector/PDMR Shareholding
9th Feb 20243:28 pmRNSHolding(s) in Company
18th Jan 20241:33 pmRNSHolding(s) in Company
11th Jan 20243:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:00 amRNSDirectorate Change
12th Dec 20233:08 pmRNSDirector/PDMR Shareholding
11th Dec 202311:39 amRNSDirector Declaration
29th Nov 20234:54 pmRNSHolding(s) in Company
28th Nov 20239:35 amRNSDirector/PDMR Shareholding
24th Nov 202311:33 amRNSHolding(s) in Company
14th Nov 20239:40 amRNSDirector/PDMR Shareholding
19th Oct 202311:19 amRNSHolding(s) in Company
19th Oct 202310:34 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.